These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 23296171)

  • 21. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Framingham study insights on diabetes and cardiovascular disease.
    Kannel WB
    Clin Chem; 2011 Feb; 57(2):338-9. PubMed ID: 20837786
    [No Abstract]   [Full Text] [Related]  

  • 23. Glycemic control and cardiovascular mortality.
    Riddle MC
    Curr Opin Endocrinol Diabetes Obes; 2011 Apr; 18(2):104-9. PubMed ID: 21522000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Common Therapeutic Modalities Against Diabetes and Associated Cardiovascular Disease.
    Jabir NR; Firoz CK; Ashraf GM; Zaidi SK; Shakil S; Kamal MA; Tabrez S
    Curr Vasc Pharmacol; 2017; 15(4):365-373. PubMed ID: 28056755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes management: More than just cardiovascular risk?
    Zimmerman RS; Pantalone KM
    Cleve Clin J Med; 2014 Nov; 81(11):672-6. PubMed ID: 25368217
    [No Abstract]   [Full Text] [Related]  

  • 26. Mammalian target of rapamycin signaling in diabetic cardiovascular disease.
    Chong ZZ; Maiese K
    Cardiovasc Diabetol; 2012 Jul; 11():45. PubMed ID: 22545721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in metabolic disorders: hypercholesterolaemia and diabetes].
    Strawn WB
    Drugs; 2002; 62 Spec No 1():31-41. PubMed ID: 12036387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of Vascular Complications in Diabetes Mellitus Patients: Focus on the Arterial Wall.
    Lunder M; Janić M; Šabovič M
    Curr Vasc Pharmacol; 2019; 17(1):6-15. PubMed ID: 29412116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atherogenesis and atherothrombosis--focus on diabetes mellitus.
    Stratmann B; Tschoepe D
    Best Pract Res Clin Endocrinol Metab; 2009 Jun; 23(3):291-303. PubMed ID: 19520304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International symposium on complications of diabetes--current status of prevention and treatment. The Hague, The Netherlands, March 2-5, 1986.
    Transplant Proc; 1986 Dec; 18(6):1471-861. PubMed ID: 3097894
    [No Abstract]   [Full Text] [Related]  

  • 31. The relationship between glycaemic variability and cardiovascular autonomic dysfunction in patients with type 1 diabetes: A systematic review.
    Helleputte S; De Backer T; Lapauw B; Shadid S; Celie B; Van Eetvelde B; Vanden Wyngaert K; Calders P
    Diabetes Metab Res Rev; 2020 Jul; 36(5):e3301. PubMed ID: 32073212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. International Diabetes Federation World Diabetes Congress 2015.
    Gao HX; Regier EE; Close KL
    J Diabetes; 2016 May; 8(3):300-2. PubMed ID: 26778343
    [No Abstract]   [Full Text] [Related]  

  • 33. Insulin and insulin resistance: impact on blood pressure and cardiovascular disease.
    Sowers JR; Frohlich ED
    Med Clin North Am; 2004 Jan; 88(1):63-82. PubMed ID: 14871051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial dysfunction: the common consequence in diabetes and hypertension.
    Wong WT; Wong SL; Tian XY; Huang Y
    J Cardiovasc Pharmacol; 2010 Apr; 55(4):300-7. PubMed ID: 20422734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overview of the importance of glycaemic control for cardiovascular events in the in-and out-patient setting.
    Anselmino M; Malmberg K; Mellbin L; Rydén L
    Rev Endocr Metab Disord; 2010 Mar; 11(1):87-94. PubMed ID: 20204530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ECG vertigo in diabetes and cardiac autonomic neuropathy.
    Voulgari C; Tentolouris N; Stefanadis C
    Exp Diabetes Res; 2011; 2011():687624. PubMed ID: 21747831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversibility of endothelial dysfunction in diabetes: role of polyphenols.
    Suganya N; Bhakkiyalakshmi E; Sarada DV; Ramkumar KM
    Br J Nutr; 2016 Jul; 116(2):223-46. PubMed ID: 27264638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cardiorenal syndrome in diabetes mellitus.
    Karnib HH; Ziyadeh FN
    Diabetes Res Clin Pract; 2010 Sep; 89(3):201-8. PubMed ID: 20599286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The extent to which statins have improved cardiovascular outcomes: Lessons from randomized trials and observational studies of "real world" practice in people with diabetes.
    Bengaluru Jayanna M; Robinson JG
    Diabetes Obes Metab; 2019 Apr; 21 Suppl 1():17-27. PubMed ID: 31002457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-transplant diabetes mellitus. The role of immunosuppression.
    Jindal RM; Sidner RA; Milgrom ML
    Drug Saf; 1997 Apr; 16(4):242-57. PubMed ID: 9113492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.